Your institution may have access to this item. Find your institution then sign in to continue.
Title
Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder.
Authors
Wolraich, M L; Greenhill, L L; Pelham, W; Swanson, J; Wilens, T; Palumbo, D; Atkins, M; McBurnett, K; Bukstein, O; August, G
Abstract
A new once-a-day methylphenidate (MPH) formulation, Concerta (methylphenidate HCl) extended-release tablets (OROS MPH), has been developed. This study was conducted to determine the safety and efficacy of OROS MPH in a multicenter, randomized, clinical trial.